S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
We Called (ARWR) In Advance, Which Stocks Are Next? (Ad)
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
Slow start to New York's legal pot market leaves farmers holding the bag
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
Apple is expected to unveil a sleek, pricey headset. Is it the device VR has been looking for?
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Free SMS Trade Alerts. Up to 15 opportunities a day. (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:ACHV

Achieve Life Sciences (ACHV) Earnings Date, Estimates & Call Transcripts

$6.74
+0.28 (+4.33%)
(As of 06/2/2023 ET)
Compare
Today's Range
$6.54
▼
$6.89
50-Day Range
$5.13
▼
$9.93
52-Week Range
$2.00
▼
$10.30
Volume
144,577 shs
Average Volume
264,508 shs
Market Capitalization
$121.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.67
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media

Earnings Summary

Upcoming
Earnings Date
Aug. 10Estimated
Actual EPS
(Mar. 16)
-$0.83 Beat By $0.07
Consensus EPS
(Mar. 16)
-$0.90
Last Year's Q1 EPS
(3/10/2022)
-$0.76
Read Call Transcript
Listen to Call
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ACHV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ACHV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Achieve Life Sciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20231($0.67)($0.67)($0.67)
Q2 20232($0.49)($0.40)($0.45)
Q3 20232($0.43)($0.37)($0.40)
Q4 20232($0.43)($0.32)($0.38)
FY 20237($2.02)($1.76)($1.89)

ACHV Earnings Date and Information

Achieve Life Sciences last posted its earnings results on March 16th, 2023. The biopharmaceutical company reported ($0.83) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.07. Achieve Life Sciences has generated ($3.76) earnings per share over the last year (($3.76) diluted earnings per share). Earnings for Achieve Life Sciences are expected to grow in the coming year, from ($1.59) to ($1.44) per share. Achieve Life Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off prior year's report dates.

Achieve Life Sciences Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/10/2023
(Estimated)		        
3/16/2023Q4 2022($0.90)($0.83)+$0.07($0.83)    
11/14/2022Q3 2022($1.10)($1.35)($0.25)($1.35)
8/11/2022Q2 2022($0.79)($1.08)($0.29)($1.08)    
5/12/2022Q1 2022($0.82)($0.80)+$0.02($0.80)    
3/10/2022Q4 2021($0.73)($0.76)($0.03)($0.76)    
11/9/20219/30/2021($1.09)($0.71)+$0.38($0.71)    
8/10/20216/30/2021($1.23)($1.53)($0.30)($1.53)    
5/12/20213/31/2021($0.78)($1.30)($0.52)($1.30)  
3/11/202112/31/2020($1.27)($1.11)+$0.16($1.11)  
11/17/20209/30/2020($1.30)($1.14)+$0.16($1.14)  
8/6/20206/30/2020($3.80)($1.68)+$2.12($1.68)  
5/14/20203/31/2020($2.40)($2.20)+$0.20($0.11)  
3/13/202012/31/2019($5.40)($6.00)($0.60)($0.30)  
11/6/2019Q3($4.40)($9.00)($4.60)($0.45)  
8/8/2019Q2 2019($6.60)($10.00)($3.40)($0.50)
5/15/2019Q1 2019($17.60)($17.60)($0.88)
3/14/201912/31/2018($7.40)($11.00)($3.60)($0.55)
11/8/20189/30/2018($25.60)($14.20)+$11.40($0.71)  
8/8/2018Q2 2018($36.40)($36.40)($1.82)
5/9/2018Q1 2018($48.00)($48.00)($0.24)
3/1/2018Q4 2017($64.00)($64.00)($0.32)
11/9/2017Q3 2017($180.00)($180.00)($0.90)
7/31/2017Q2 2017($20.00)($20.00)($0.10)
5/15/2017Q1 2017($58.00)($22.40)+$35.60($0.11)
2/23/2017Q4 2016($418.00)($418.00)($2.09)
11/10/2016Q3 2016($352.00)($352.00)($22.00)
8/4/2016Q2 2016($308.00)($396.00)($88.00)($14.30)$1.17 million$2.10 million
5/12/2016Q1 2016($154.00)($242.00)($88.00)($11.00)$4.09 million$2.90 million  
3/9/2016Q4 2015($484.00)($132.00)+$352.00($6.60)$6.00 million$6.02 million
11/12/2015Q3 2015($484.00)($352.00)+$132.00($17.60)$5.97 million$6.74 million  
8/13/2015Q2 2015$330.00($572.00)($902.00)($28.60)$16.10 million$4.03 million  
5/14/2015Q1 2015($770.00)($440.00)+$330.00($22.00)$4.66 million$1.40 million  
3/26/2015Q4 2014($638.00)($594.00)+$44.00($30.80)$4.30 million$5.70 million
10/30/2014Q3 2014($836.00)($506.00)+$330.00($25.30)$4.69 million$4.80 million  
8/7/2014Q2 2014($1,078.20)($1,034.20)+$44.00($51.71)$11.73 million$4.93 million
4/30/2014Q1 2014($968.00)($1,298.20)($330.20)($64.91)$8.68 million$11.73 million  
3/11/2014Q4 2013($1,364.20)($990.00)+$374.20($49.50)$10.20 million$8.60 million
11/7/2013Q3 2013($1,518.00)($1,496.00)+$22.00($7.48)$6.67 million$9.86 million
8/8/2013Q2 2013($1,386.00)($1,254.00)+$132.00($6.27)$5.97 million$6.34 million
5/2/2013Q1 2013($1,496.00)($1,232.00)+$264.00($7.26)$5.28 million$5.08 million
3/7/2013Q4 2012($1,078.00)($858.00)+$220.00($5.50)
11/8/2012Q312($98.00)($80.00)+$18.00$4.52 million$6.57 million  
8/2/2012Q2 2012($1,188.00)($638.00)+$550.00($3.19)
5/3/2012Q1 2012($1,518.00)($1,172.00)+$346.00($4.35)
3/8/2012Q4 2011($1,298.00)($2,158.00)($860.00)($10.79)
11/3/2011Q3 2011($1,188.00)($980.00)+$208.00($4.90)
8/4/2011Q2 2011($1,210.00)($1,478.00)($268.00)($7.39)
5/9/2011Q1 2011($990.00)($1,164.00)($174.00)($8.20)
3/10/2011Q4 2010($1,056.00)$690.00+$1,746.00$3.45
11/4/2010Q3 2010($1,034.00)($2,350.00)($1,316.00)($11.75)
8/5/2010Q2 2010($990.00)($960.00)+$30.00($9.86)
5/6/2010Q1 2010($990.00)($1,058.00)($68.00)($5.29)
3/8/2010Q4 2009$418.00($1,408.00)($1,826.00)($7.04)
11/5/2009Q3 2009($1,320.00)($870.00)+$450.00($4.35)
8/6/2009Q2 2009($1,210.00)($1,808.00)($598.00)($9.04)
5/7/2009Q1 2009($954.00)($954.00)($4.77)
3/11/2009Q4 2008($2,178.00)($2,178.00)($10.89)
11/10/2008Q3 2008$156.00+$156.00($22.91)
3/5/2008Q4 2007($10,684.00)$2,058.00+$12,742.00$10.29












Achieve Life Sciences Earnings - Frequently Asked Questions

When is Achieve Life Sciences's earnings date?

Achieve Life Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 10th, 2023 based off last year's report dates. Learn more on ACHV's earnings history.

Did Achieve Life Sciences beat their earnings estimates last quarter?

In the previous quarter, Achieve Life Sciences (NASDAQ:ACHV) reported ($0.83) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.90) by $0.07. Learn more on analysts' earnings estimate vs. ACHV's actual earnings.

How can I listen to Achieve Life Sciences's earnings conference call?

The conference call for Achieve Life Sciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Achieve Life Sciences's conference call transcript?

The conference call transcript for Achieve Life Sciences's latest earnings report can be read online. Read Transcript

How much profit does Achieve Life Sciences generate each year?

Achieve Life Sciences (NASDAQ:ACHV) has a recorded net income of -$42.35 million. ACHV has generated -$3.76 earnings per share over the last four quarters.

What is Achieve Life Sciences's EPS forecast for next year?

Achieve Life Sciences's earnings are expected to grow from ($1.59) per share to ($1.44) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:ACHV) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -